Literature DB >> 2426194

Immunodominance in the T-cell response to multiple non-H-2 histocompatibility antigens. II. Observation of a hierarchy among dominant antigens.

P J Wettstein.   

Abstract

Immunization of C57BL/6 mice with BALB.B spleen cells in vivo and subsequent boosting in mixed lymphocyte culture result in the generation of cytolytic T lymphocytes (CTLs) which are specific for a limited number of immunodominant antigens. Experiments are described which suggest the existence of a hierarchy of immunodominance in this donor: host combination. Two antigens, CTT-1.3 and CTT-2.3, are dominant in the C57BL/6 anti-BALB.B CTL response. The distribution of these antigens among CXB recombinant inbred (RI) strains suggests that they segregate as single gene traits. Elimination of the CTT-1.3 and CTT-2.3 antigens by complementation in the responder, or elimination from the priming and boosting stages by the selection of CXB RI strain mice as responders or stimulators, reveals a second level of immunodominant antigens which include CTT-3.3 and CTT-4.3. CXB mice which express one of the CTT-1.3 or CTT-2.3 antigens will produce CTLs specific for the other antigen upon priming and boosting with BALB.B cells. Expression of both antigens in responders results in the generation of CTLs specific for the second level, dominant antigens. Immunodominance is not confined to the C57BL/6 anti-BALB.B system but can also be observed in the BALB.B anti-C57BL/6 and B10.D2 anti-DBA/2 systems. Finally, generation of CTLs following priming and boosting with dominant and dominated antigens presented on different cells confirmed that immunodominance can only be observed when the dominant and dominated antigens are presented on the same cells. These observations suggest that immunodominance is revealed at the level of antigen-presenting cells primarily involved in vivo priming.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2426194     DOI: 10.1007/bf00372294

Source DB:  PubMed          Journal:  Immunogenetics        ISSN: 0093-7711            Impact factor:   2.846


  17 in total

1.  A REVISION OF THE STANDARDIZED GENETIC NOMENCLATURE FOR MICE.

Authors:  M C GREEN; H GRUENEBERG; P HERTWIG; W E HESTON; M F LYON; N N MEDVEDEV; G D SNELL; J STAATS
Journal:  J Hered       Date:  1963 Jul-Aug       Impact factor: 2.645

2.  Immune responses in vitro. I. Culture conditions for antibody synthesis.

Authors:  R E Click; L Benck; B J Alter
Journal:  Cell Immunol       Date:  1972-02       Impact factor: 4.868

3.  A miniaturized mouse mixed leukocyte culture in serum-free and mouse serum supplemented media.

Authors:  A B Peck; F H Bach
Journal:  J Immunol Methods       Date:  1973-10       Impact factor: 2.303

4.  Estimates of the number of loci contributing to the histoincompatibility between C57BL-6 and BALB-c strains of mice.

Authors:  D W Bailey; L E Mobraaten
Journal:  Transplantation       Date:  1969-05       Impact factor: 4.939

5.  Recombinant-inbred strains. An aid to finding identity, linkage, and function of histocompatibility and other genes.

Authors:  D W Bailey
Journal:  Transplantation       Date:  1971-03       Impact factor: 4.939

6.  Genetic control of the cytotoxic T cell response to SV40 tumor-associated specific antigen.

Authors:  B B Knowles; M Koncar; K Pfizenmaier; D Solter; D P Aden; G Trinchieri
Journal:  J Immunol       Date:  1979-05       Impact factor: 5.422

7.  Qed-1--a target for unrestricted killing by T cells.

Authors:  K F Lindahl; B Hausmann
Journal:  Eur J Immunol       Date:  1980-04       Impact factor: 5.532

8.  Ir-genes in H-2 regulate generation of anti-viral cytotoxic T cells. Mapping to K or D and dominance of unresponsiveness.

Authors:  R M Zinkernagel; A Althage; S Cooper; G Kreeb; P A Klein; B Sefton; L Flaherty; J Stimpfling; D Shreffler; J Klein
Journal:  J Exp Med       Date:  1978-08-01       Impact factor: 14.307

9.  Cytotoxic T-cell responses in mice infected with influenza and vaccinia viruses vary in magnitude with H-2 genotype.

Authors:  P C Doherty; W E Biddison; J R Bennink; B B Knowles
Journal:  J Exp Med       Date:  1978-08-01       Impact factor: 14.307

10.  Selective response to H-Y antigen by F1 female mice sensitized to F1 male cells.

Authors:  R D Gordon; L E Samelson; E Simpson
Journal:  J Exp Med       Date:  1977-08-01       Impact factor: 14.307

View more
  9 in total

1.  Identification of an immunodominant mouse minor histocompatibility antigen (MiHA). T cell response to a single dominant MiHA causes graft-versus-host disease.

Authors:  C Perreault; J Jutras; D C Roy; J G Filep; S Brochu
Journal:  J Clin Invest       Date:  1996-08-01       Impact factor: 14.808

2.  Immunodominance in the T-cell response to multiple non-H-2 histocompatibility antigens. V. Chromosomal mapping of the immunodominant cytotoxic T-cell target-1 (CTT-1).

Authors:  M Vagliani; C Melani; G Parmiani; P D'Eustachio; P J Wettstein; M P Colombo
Journal:  Immunogenetics       Date:  1993       Impact factor: 2.846

3.  H4 and CTT-2 minor histocompatibility antigens: concordant genetic linkage and migration in two-dimensional peptide separation.

Authors:  W K Nevala; P J Wettstein
Journal:  Immunogenetics       Date:  1996       Impact factor: 2.846

4.  T-cell receptor V(alpha) usage by effector CD4+Vbeta11+ T cells mediating graft-versus-host disease directed to minor histocompatibility antigens.

Authors:  Christine G DiRienzo; George F Murphy; Thea M Friedman; Robert Korngold
Journal:  Biol Blood Marrow Transplant       Date:  2007-03       Impact factor: 5.742

5.  Differences in MHC-class I presented minor histocompatibility antigens extracted from normal and graft-versus-host disease (GVHD) mice.

Authors:  M Bruley Rosset; V Tieng; D Charron; A Toubert
Journal:  Clin Exp Immunol       Date:  2003-04       Impact factor: 4.330

6.  Characterization of CTL Clones Specific for Single Antigen, H60 Minor Histocompatibility Antigen.

Authors:  Ji Yeong Jeon; Kyung Min Jung; Jun Chang; Eun Young Choi
Journal:  Immune Netw       Date:  2011-04-30       Impact factor: 6.303

7.  Incomplete CD8(+) T lymphocyte differentiation as a mechanism for subdominant cytotoxic T lymphocyte responses to a viral antigen.

Authors:  J V Spencer; T J Braciale
Journal:  J Exp Med       Date:  2000-05-15       Impact factor: 14.307

8.  Variable capacity of L3T4+ T cells to cause lethal graft-versus-host disease across minor histocompatibility barriers in mice.

Authors:  R Korngold; J Sprent
Journal:  J Exp Med       Date:  1987-06-01       Impact factor: 14.307

Review 9.  Old game, new players: Linking classical theories to new trends in transplant immunology.

Authors:  Marina Burgos da Silva; Flavia Franco da Cunha; Fernanda Fernandes Terra; Niels Olsen Saraiva Camara
Journal:  World J Transplant       Date:  2017-02-24
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.